Pharmacogenomics (journal): Difference between revisions
No edit summary |
Laura Dormer (talk | contribs) m Updated impact factor following new JCR release |
||
| Line 12: | Line 12: | ||
| openaccess = |
| openaccess = |
||
| license = |
| license = |
||
| impact = 2. |
| impact = 2.350 |
||
| impact-year = |
| impact-year = 2016 |
||
| ISSN = 1462-2416 |
| ISSN = 1462-2416 |
||
| eISSN = 1744-8042 |
| eISSN = 1744-8042 |
||
| Line 29: | Line 29: | ||
== Abstracting and indexing == |
== Abstracting and indexing == |
||
The journal is abstracted and indexed in [[Biological Abstracts]], [[BIOSIS Previews]], [[Biotechnology Citation Index]], [[Chemical Abstracts]], [[Current Contents]]/Life Sciences, [[EMBASE]]/[[Excerpta Medica]], [[Index Medicus]]/[[MEDLINE]]/[[PubMed]], [[Science Citation Index]], and [[Scopus]]. According to the ''[[Journal Citation Reports]]'', the journal has a |
The journal is abstracted and indexed in [[Biological Abstracts]], [[BIOSIS Previews]], [[Biotechnology Citation Index]], [[Chemical Abstracts]], [[Current Contents]]/Life Sciences, [[EMBASE]]/[[Excerpta Medica]], [[Index Medicus]]/[[MEDLINE]]/[[PubMed]], [[Science Citation Index]], and [[Scopus]]. According to the ''[[Journal Citation Reports]]'', the journal has a 2016 [[impact factor]] of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".<ref name=WoS>{{cite book |year=2017 |chapter=Journals Ranked by Impact: Pharmacology & Pharmacy |title=2016 Journal Citation Reports |publisher=[[Thomson Reuters]] |edition=Science |series=[[Web of Science]]}}</ref> |
||
== References == |
== References == |
||
Revision as of 11:31, 29 June 2017
 | |
| Discipline | Pharmacogenomics |
|---|---|
| Language | English |
| Edited by | David Gurwitz, Howard McLeod, Munir Pirmohamed |
| Publication details | |
| History | 2000–present |
| Publisher | |
| Frequency | 18/year |
| 2.350 (2016) | |
| Standard abbreviations | |
| ISO 4 | Pharmacogenomics |
| Indexing | |
| CODEN | PARMFL |
| ISSN | 1462-2416 (print) 1744-8042 (web) |
| OCLC no. | 55059877 |
| Links | |
Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.
Abstracting and indexing
The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]
References
- ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.